| Identification | Back Directory | [Name]
N-(tert-Butyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide | [CAS]
936091-15-5 | [Synonyms]
TG-46
RS0111
EX-8668
SCHEMBL264717
NCGC00345846-01
TG-46 (derivative 2)
1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]-
N-(tert-Butyl)-3-((5-methyl-2-((4-(morpholinomethyl)phenyl)-amino)pyrimidin-4-yl)amino)benzene
N-tert-butyl-3-(5-methyl-2-(4-(morpholinomethyl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide
N-(tert-Butyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide
Benzenesulfonamide, N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]-
936091-15-5; SCHEMBL264717; RS0111; EX-8668; NCGC00345846-01; BENZENESULFONAMIDE; N-(1;1-DIMETHYLETHYL)-3-[[5-METHYL-2-[[4-(4-MORPHOLINYLMETHYL)PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]- | [Molecular Formula]
C26H34N6O3S | [MDL Number]
MFCD17019342 | [MOL File]
936091-15-5.mol | [Molecular Weight]
510.65 |
| Hazard Information | Back Directory | [Description]
TG-46 is an inhibitor of JAK2, FLT3, RET, JAK3. | [Uses]
JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1]. | [References]
[1] Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1. |
|
| Company Name: |
Lynnchem
|
| Tel: |
86-(0)29-85992781 17792393971 |
| Website: |
http://www.lynnchem.com/ |
| Company Name: |
Novachemistry
|
| Tel: |
44-20819178-90 02081917890 |
| Website: |
https://www.novachemistry.com/ |
| Company Name: |
Henan Alfachem Co.,Ltd.
|
| Tel: |
0371-55051623 18137891487 |
| Website: |
www.approvedhomemanagement.com/supplier/14555231/ |
|